Azenta, Inc.
Company Information
Industry Special Industry Machinery, NEC
SIC Code 3559
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 200 SUMMIT DRIVE, BURLINGTON, MA, 01803
Mailing Address 200 SUMMIT DRIVE, BURLINGTON, MA, 01803
Phone (978) 262-2400
Fiscal Year End 0930
EIN 043040660
Financial Overview
FY2025
$1.77B
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4/A Insider transaction amendment | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 4 Insider stock transaction report | February 6, 2026 | View on SEC |
| 10-Q Quarterly financial report | February 5, 2026 | View on SEC |
| 8-K Current report of material events | February 4, 2026 | View on SEC |
Annual Reports
10-K December 4, 2025
- Azenta helps healthcare and life sciences companies with biological sample storage/management and automation solutions.
- The company operates through two main business segments: Sample Management Solutions and Multiomics.
Related Companies
Companies in the same industry (SIC: 3559)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.